HCV genotypes and serum RNA levels in HCV-related cirrhosis with or without hepatocellular carcinoma (HCC).

被引：0
|
作者：
Adinolfi, LE [1 ]
Utili, R [1 ]
Andreana, A [1 ]
Ragone, E [1 ]
Cristiano, F [1 ]
Tonziello, A [1 ]
Mormone, G [1 ]
Gambardella, M [1 ]
Bellopede, P [1 ]
Rosario, P [1 ]
Marrone, A [1 ]
Ruggiero, G [1 ]
机构：
[1] UNIV NAPLES 2,FAC MED,INST MED THERAPY,NAPLES,ITALY
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [21] IMPACT OF OCCULT HBV INFECTION IN HEPATOCELLULAR CARCINOMA PRESENTATION IN HCV-RELATED CIRRHOSIS
    Coppola, N.
    Iodice, V.
    Starace, M.
    Minichini, C.
    Farella, N.
    Onorato, L.
    Liorre, G.
    Sagnelli, E.
    De Stefano, G.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S374 - S374
  • [22] Increasing survival in HCV-related hepatocellular carcinoma
    Ray K.
    Nature Reviews Gastroenterology & Hepatology, 2019, 16 (10) : 582 - 582
  • [23] Treatment of HCV-related cirrhosis
    Mallat, A.
    JOURNAL AFRICAIN D HEPATO-GASTROENTEROLOGIE, 2007, 1 (01): : 59 - 62
  • [24] IMPACT OF OCCULT HBV INFECTION IN HCC PRESENTATION IN HCV-RELATED CIRRHOSIS
    Coppola, N.
    Iodice, V.
    Farella, N.
    Liorre, G.
    Minichini, C.
    Starace, M.
    Onorato, L.
    Sagnelli, E.
    de Stefano, G.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E134 - E134
  • [25] Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma
    Li, Jian
    Jin, Boxun
    Wang, Tiezheng
    Li, Wenlei
    Wang, Zhenshun
    Zhang, Haitao
    Song, Yunjun
    Li, Ning
    CANCER BIOMARKERS, 2019, 26 (04) : 501 - 512
  • [26] Serum albumin is present at higher levels in alcoholic liver cirrhosis as compared to HCV-related cirrhosis
    Kotoh, Kazuhiro
    Fukushima, Marie
    Horikawa, Yuki
    Yamashita, Shinsaku
    Kohjima, Motoyuki
    Nakamuta, Makoto
    Enjoji, Munechika
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (01) : 72 - 75
  • [27] Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis
    Stroffolini, Tommaso
    Almasio, Piero Luigi
    Persico, Marcello
    Bollani, Simona
    Benvegnu, Luisa
    Di Costanzo, GiovanGiuseppe
    Pastore, Giuseppe
    Aghemo, Alessio
    Stornaiuolo, Gianfranca
    Mangia, Alessandra
    Andreone, Pietro
    Stanzione, Maria
    Mazzella, Giuseppe
    Saracco, Giorgio
    Del Poggio, Paolo
    Bruno, Savino
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (08) : 1966 - 1972
  • [28] Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis
    Mazzella, G
    Accogli, E
    Sottili, S
    Festi, D
    Orsini, M
    Salzetta, A
    Novelli, V
    Cipolla, A
    Fabbri, C
    Pezzoli, A
    Roda, E
    JOURNAL OF HEPATOLOGY, 1996, 24 (02) : 141 - 147
  • [29] IMPACT OF HEPATITIS C VIRUS (HCV) TREATMENT, TYPE OF HEPATOCELLULAR CARCINOMA (HCC) TREATMENT, AND ETHNICITY ON OVERALL SURVIVAL IN PATIENTS WITH HCV-RELATED HCC
    Nguyen, Veronica
    Arteaga, Christopher
    Anderson, Colin
    Cui, Haiyan
    Roe, Denise
    Shroff, Rachna T.
    HEPATOLOGY, 2021, 74 : 647A - 647A
  • [30] A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis
    Nahon, Pierre
    Sutton, Angela
    Rufat, Pierre
    Charnaux, Nathalie
    Mansouri, Abdellah
    Moreau, Richard
    Ganne-Carrie, Nathalie
    Grando-Lemaire, Veronique
    N'Kontchou, Gisele
    Trinchet, Jean-Claude
    Pessayre, Dominique
    Beaugrand, Michel
    JOURNAL OF HEPATOLOGY, 2012, 56 (02) : 426 - 432
12345